These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


418 related items for PubMed ID: 18193796

  • 1. [Renal function and pharmacotherapy in children].
    Jovanović O.
    Srp Arh Celok Lek; 1995 Jun; 123 Suppl 1():15-21. PubMed ID: 18193796
    [Abstract] [Full Text] [Related]

  • 2. Drug dosing guidelines in patients with renal failure.
    Swan SK, Bennett WM.
    West J Med; 1992 Jun; 156(6):633-8. PubMed ID: 1615656
    [Abstract] [Full Text] [Related]

  • 3. Drug dosing in chronic kidney disease.
    Gabardi S, Abramson S.
    Med Clin North Am; 2005 May; 89(3):649-87. PubMed ID: 15755472
    [Abstract] [Full Text] [Related]

  • 4. Drug disposition during the perinatal period.
    Heimann G.
    Int J Biol Res Pregnancy; 1981 May; 2(1):1-14. PubMed ID: 7341492
    [Abstract] [Full Text] [Related]

  • 5. [Iatrogenic kidney diseases].
    Rutkowski B.
    Pol Merkur Lekarski; 2010 Jan; 28(163):66-70. PubMed ID: 20369729
    [Abstract] [Full Text] [Related]

  • 6. [Pharmacokinetic bases of dosage adaptation of drugs in renal insufficiency].
    Lesne M.
    J Pharm Belg; 1988 Jan; 43(3):212-32. PubMed ID: 3171871
    [No Abstract] [Full Text] [Related]

  • 7. Drug dosing adjustments in patients with chronic kidney disease.
    Munar MY, Singh H.
    Am Fam Physician; 2007 May 15; 75(10):1487-96. PubMed ID: 17555141
    [Abstract] [Full Text] [Related]

  • 8. Drug misadventuring in neonatal nephrology.
    Fanos V, Cataldi L.
    Pediatr Med Chir; 2002 May 15; 24(2):150-6. PubMed ID: 11987523
    [Abstract] [Full Text] [Related]

  • 9. Drugs and the kidney.
    Evans DB.
    Br J Hosp Med; 1980 Sep 15; 24(3):244, 246-7, 249-51. PubMed ID: 7437614
    [Abstract] [Full Text] [Related]

  • 10. Consequences of renal insufficiency on the hepatic clearance of some drugs.
    Balant LP, Dayer P, Fabre J.
    Int J Clin Pharmacol Res; 1983 Sep 15; 3(6):459-74. PubMed ID: 6147317
    [Abstract] [Full Text] [Related]

  • 11. Altered disposition of drugs in acute renal failure rat models: drug development strategies and perspectives.
    Srinivas NR.
    Arzneimittelforschung; 2010 Sep 15; 60(12):731-48. PubMed ID: 21265465
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic implications of renal anionic drug transporters.
    Masereeuw R, Russel FG.
    Pharmacol Ther; 2010 May 15; 126(2):200-16. PubMed ID: 20227439
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R.
    Nefrologia; 2008 May 15; 28 Suppl 3():87-93. PubMed ID: 19018744
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Disease-induced modifications of drug pharmacokinetics.
    Barre J, Houin G, Brunner F, Bree F, Tillement JP.
    Int J Clin Pharmacol Res; 1983 May 15; 3(4):215-26. PubMed ID: 6381335
    [Abstract] [Full Text] [Related]

  • 19. [Clinicobiological study of drug-induced renal diseases].
    Hadj-Aissa A, Laville M, Couder J, Souquet JC, Chayvialle JA, Pozet N.
    Ann Biol Clin (Paris); 1989 May 15; 47(6):346-50. PubMed ID: 2528928
    [Abstract] [Full Text] [Related]

  • 20. Influence of obesity on drug disposition.
    Blouin RA, Kolpek JH, Mann HJ.
    Clin Pharm; 1987 Sep 15; 6(9):706-14. PubMed ID: 3315402
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.